Lawrence David Mayer serves as Executive at Celator Pharmaceuticals Inc, where they oversee executive responsibilities. Since joining the company, Lawrence David Mayer has executed 9 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 12, 2016 involved selling 7,468 shares valued at $225.9K.
Lawrence David Mayer currently holds 107,515 shares of Celator Pharmaceuticals Inc (NONE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lawrence David Mayer has been a net neutral trader of NONE stock. They have purchased $0 and sold $0 worth of shares.
Lawrence David Mayer's most recent insider trade was on Jul 12, 2016, when they sold 7,468 shares at $30.25 per share.
Get notified when new Form 4 filings are submitted
| 3,631 |
| $30.25 |
| Discretionary |
| Jul 12, 2016 | CPXX | $3.3M | Disposition | 107,515 | $30.25 | Discretionary |
| Mar 15, 2016 | CPXX | $108.0K | Payment | 12,081 | $8.94 | Discretionary |
| Mar 15, 2016 | CPXX | $108.0K | Option Exercise | 48,002 | $2.25 | Discretionary |
| May 14, 2015 | CPXX | $123.8K | Option Exercise | 55,000 | $2.25 | Discretionary |
| Feb 25, 2015 | CPXX | $0 | Award | 7,639 | $N/A | Discretionary |
| Feb 25, 2015 | CPXX | $0 | Award | 6,133 | $N/A | Discretionary |
| Nov 6, 2013 | NONE | $6.7K | Option Exercise | 2,401 | $2.81 | Discretionary |